Role of alpha-synuclein protein levels in mitochondrial morphology and cell survival in cell lines.

PloS One
Min ZhuChuanzhen Lu

Abstract

α-Synuclein is highly associated with some neurodegeneration and malignancies. Overexpressing wild-type or mutant α-synuclein promotes neuronal death by mitochondrial dysfunction, the underlying mechanisms of which remain poorly defined. It was recently reported that α-synuclein expression could directly lead to mitochondrial fragmentation in vitro and in vivo, which may be due to α-synuclein localization on mitochondria. Here, we applied a double staining method to demonstrate mitochondrial morphogenetic changes in cells overexpressed with α-synuclein. We show that mitochondrial localization of α-synuclein was increased following its overexpression in three distinct cell lines, including HeLa, SH-SY5Y, and PC12 cells, but no alteration in mitochondrial morphology was detected. However, α-synuclein knockdown prevents MPP(+)-induced mitochondrial fragmentation in SH-SY5Y and PC12 cells. These data suggest that α-synuclein protein levels hardly affect mitochondrial morphology in normal cell lines, but may have some influence on that under certain environmental conditions.

References

Nov 1, 1974·Developmental Psychobiology·N L BanikT Scott
Feb 15, 1994·Microscopy Research and Technique·J Bereiter-Hahn, M Vöth
Aug 28, 1997·Nature·M G SpillantiniM Goedert
Jan 1, 1997·Human Molecular Genetics·R L Nussbaum, M H Polymeropoulos
Feb 3, 1999·JAMA : the Journal of the American Medical Association·C M TannerJ W Langston
Jul 19, 2000·Biochimica Et Biophysica Acta·A Iwai
Jan 22, 2001·The Journal of Biological Chemistry·V N UverskyA L Fink
Oct 12, 2002·Proceedings of the National Academy of Sciences of the United States of America·William DauerRene Hen
Jun 5, 2003·Acta Neuropathologica·Kar-Ming FungJohn Q Trojanowski
Sep 23, 2003·Journal of Cellular Physiology·Maria Giuliana VannucchiMaria-Simonetta Faussone-Pellegrini
Feb 21, 2004·Current Topics in Developmental Biology·Hsiuchen Chen, David C Chan
Feb 24, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Ann E KingsburyOliver J F Foster
Mar 5, 2004·Journal of Molecular Neuroscience : MN·Svetlana LticSelma Kanazir
Jul 9, 2004·Progress in Neurobiology·O von Bohlen und HalbachK Krieglstein
Jul 28, 2004·Neurology·Karin WirdefeldtNancy L Pedersen
Nov 18, 2004·Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·Ravi RaghavanCharles L White
Jan 14, 2005·American Journal of Physiology. Cell Physiology·Werner J H KoopmanPeter H G M Willems
Jan 10, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Lee J MartinMichael K Lee
Apr 7, 2007·Human Molecular Genetics·Christine C StichelHermann Lübbert
Sep 22, 2007·Neuroreport·Wen-Wei LiDing-Fang Cai
Jan 15, 2008·The Journal of Biological Chemistry·Sabrina BüttnerFrank Madeo
Mar 7, 2008·Cellular and Molecular Life Sciences : CMLS·M S PariharP Ghafourifar
Apr 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Yufeng YangBingwei Lu
Jun 24, 2008·Nature Reviews. Neuroscience·Andrew B KnottElla Bossy-Wetzel
Aug 30, 2008·Human Molecular Genetics·Iris EisenbergStella Mitrani-Rosenbaum
Dec 11, 2008·Annals of Neurology·Heather MortiboysOliver Bandmann
Feb 6, 2009·Molecular Neurodegeneration·Mark R Cookson
Oct 8, 2009·Human Molecular Genetics·Hsiuchen Chen, David C Chan
Jun 26, 2010·Cellular and Molecular Life Sciences : CMLS·Dong-Hyung ChoStuart A Lipton
Apr 15, 2011·The Journal of Biological Chemistry·Ken NakamuraRobert H Edwards
May 17, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Darlene A MitranoDavid Weinshenker

❮ Previous
Next ❯

Citations

Jan 26, 2013·International Journal of Molecular Sciences·Sarah CicconeStefania Gonfloni
Mar 15, 2014·Disease Models & Mechanisms·Kelley C O'DonnellAlvaro Sagasti
Dec 22, 2012·Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine·Min ZhuWen-wei Li
Jul 3, 2013·Current Opinion in Neurology·Eleanna KaraHenry Houlden
Jul 15, 2015·Proceedings of the National Academy of Sciences of the United States of America·Jessica M HearnPeter J Sadler
Oct 21, 2015·Pharmacology & Therapeutics·Uma A MukherjeeDerek J Hausenloy
Feb 25, 2014·Neurobiology of Aging·Matthias HöllerhageGünter U Höglinger
Feb 6, 2017·Neuroscience Letters·Jinyan DuanYulin Deng
Dec 24, 2013·The Journal of Biological Chemistry·Aung ThanPeng Chen
Mar 10, 2017·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·TaeHee Kim, Raghu Vemuganti
Nov 22, 2013·Biochemical Society Transactions·David R Brown
Jul 27, 2021·Frontiers in Aging Neuroscience·Upasana GangulySasanka Chakrabarti

❮ Previous
Next ❯

Methods Mentioned

BETA
transfect
Transfection
flow cytometry
GTPases
GTPase

Software Mentioned

Volocity

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.